Type 1 Diabetes and Diabetes Distress
Launched by ODENSE UNIVERSITY HOSPITAL · Apr 10, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to help young adults, aged 18 to 35, who have type 1 diabetes and are experiencing significant diabetes distress, which is the emotional burden that can come with managing the condition. The study will test a group-based program called ACTnow, which aims to lower this distress and improve overall mental health and blood sugar levels. Participants will be divided into two groups: one will start the ACTnow sessions right away, while the other will wait three months before beginning the program.
To join the study, participants must have been diagnosed with type 1 diabetes for at least six months, be between 18 and 35 years old, and show moderate to severe diabetes distress. They need to be fluent in Danish and receiving care at a diabetes clinic in Southern Denmark. During the program, participants will attend six online sessions every two weeks, led by a psychologist and a nurse. Each session will include mindfulness exercises, discussions about previous sessions, new topics, and assignments to work on at home. This trial is not yet recruiting participants, but it aims to provide valuable insights into how group support can benefit young adults managing diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Type 1 diabetes for at least 6 months
- • Age between 18 and 35
- • T1-DDS score ≥ 2, or T1-DDS subscale score ≥ 2
- • Treated in a diabetes clinic in the Region of Southern Denmark
- • Proficient in Danish
- Exclusion Criteria:
- • Psychiatric diagnosis: diagnosed with substance abuse, alcohol abuse, psychosis, schizophrenia or any other psychiatric diagnosis that may compromise participation in the intervention
- • Cognitive disorders such as brain injury
- • Complex challenges best suited to individual treatment
- • Current therapeutic treatment for depression, anxiety or stress
- • Not stable medication for anxiety/depression for the past two months or planned change in medication for anxiety/depression during the project period
About Odense University Hospital
Odense University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital is committed to enhancing patient outcomes and fostering collaboration among multidisciplinary teams. With a focus on translating scientific discoveries into practical applications, Odense University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous trials across various medical fields, ensuring adherence to the highest ethical and regulatory standards. Through these efforts, the hospital aims to contribute significantly to the global body of medical knowledge and improve the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Odense, , Denmark
Odense, , Denmark
Esbjerg, , Denmark
Sønderborg, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported